Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Author:

Chan Ka Kui12,Matchett Kyle B.1,Coulter Jonathan A.3,Yuen Hiu-Fung1,McCrudden Cian M.3,Zhang Shu-Dong14,Irwin Gareth W.1,Davidson Matthew A.1,Rülicke Thomas5,Schober Sophie5,Hengst Ludger6,Jaekel Heidelinde6,Platt-Higgins Angela7,Rudland Philip S.7,Mills Ken I.1,Maxwell Perry8,El-Tanani Mohamed19,Lappin Terence R.1

Affiliation:

1. Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK

2. Department of Pathology, The University of Hong Kong, Hong Kong Special Administrative Region Hong Kong 999077, China

3. School of Pharmacy, Queen's University Belfast, Belfast BT9 7AE, UK

4. Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, Londonderry BT47 6SB, UK

5. Institute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna A-1210, Austria

6. Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck A-6020, Austria

7. Institute of Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK

8. Northern Ireland Molecular Pathology Laboratory, Belfast Health & Social Care Trust, Queen's University Belfast, Belfast BT9 7AE, UK

9. Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3